SEC 13F Intelligence

Asset Advisors Investment Management, LLC / ABT

Asset Advisors Investment Management, LLC’s Abbott Laboratories Position

Does Asset Advisors Investment Management, LLC own Abbott Laboratories (ABT)? Yes110.1K shares worth $11M (+1.08% of its 13F portfolio) as of Q1 2026, down from 113.0K shares the prior filed quarter.

Position Value
$11M
Q1 2026
Shares
110.1K
% of Portfolio
+1.08%
Quarters Held
30
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $9MQ4 ’18Q1 ’19: $9MQ2 ’19: $10MQ3 ’19: $11MQ4 ’19: $11MQ4 ’19Q1 ’20: $10MQ2 ’20: $11MQ3 ’20: $13MQ4 ’20: $14MQ4 ’20Q1 ’21: $16MQ2 ’21: $15MQ3 ’21: $15MQ4 ’21: $18MQ4 ’21Q1 ’22: $15MQ2 ’22: $13MQ3 ’22: $11MQ4 ’22: $13MQ4 ’22Q1 ’23: $12MQ2 ’23: $13MQ3 ’23: $11MQ4 ’23: $12MQ4 ’23Q1 ’24: $13MQ2 ’24: $11MQ3 ’24: $12MQ4 ’24: $12MQ4 ’24Q1 ’25: $15MQ2 ’25: $15MQ3 ’25: $15MQ4 ’25: $14MQ4 ’25Q1 ’26: $11Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026110.1K$11M+1.08%
Q4 2025113.0K$14M+1.31%
Q3 2025113.6K$15M+1.44%
Q2 2025111.8K$15M+1.50%
Q1 2025111.2K$15M+1.55%
Q4 2024107.5K$12M+1.27%
Q3 2024108.5K$12M+1.29%
Q2 2024109.9K$11M+1.24%
Q1 2024111.7K$13M+1.42%
Q4 2023111.5K$12M+1.50%
Q3 2023113.8K$11M+1.48%
Q2 2023114.9K$13M+1.59%
Q1 2023117.0K$12M+1.55%
Q4 2022117.3K$13M+1.70%
Q3 2022117.9K$11M+1.63%
Q2 2022119.8K$13M+1.78%
Q1 2022124.2K$15M+1.64%
Q4 2021125.7K$18M+1.78%
Q3 2021126.0K$15M+1.66%
Q2 2021129.9K$15M+1.67%
Q1 2021131.5K$16M+1.86%
Q4 2020131.1K$14M+1.86%
Q3 2020123.7K$13M+2.03%
Q2 2020123.8K$11M+1.81%
Q1 2020125.4K$10M+1.83%
Q4 2019131.3K$11M+1.64%
Q3 2019133.5K$11M+1.79%
Q2 2019122.4K$10M+1.73%
Q1 2019116.8K$9M+1.66%
Q4 2018118.6K$9M+1.70%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Asset Advisors Investment Management, LLC’s full portfolio or all institutional holders of ABT.